|Day's Range||132.83 - 135.18|
|52 Week Range||94.42 - 135.18|
|PE Ratio (TTM)||50.20|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Move over FAANGs, when comparing the performance of the 10 Select Sector SPDR ETFs, healthcare is currently leading in the last 1-week, 6-week and 12-week performance periods. However, it appears the leadership within the healthcare sector is changing. Here's the short list with analysis.
A Relative Strength Rating upgrade for Celgene shows improving technical performance.
With biotech stocks like Celgene, Bluebird Bio and Regeneron on the move, cancer treatment developer Exelixis may be poised to pop into a new buy zone.